Literature DB >> 11014471

When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.

J Grill1, V Laithier, D Rodriguez, M A Raquin, A Pierre-Kahn, C Kalifa.   

Abstract

UNLABELLED: Progression patterns of optic pathway tumours (OPT) need to be precisely defined for treatment planning. In patients with neurofibromatosis type 1 (NF1), this disease is usually indolent and the available literature rarely reports progression after the age of 6 years. In patients without NF1, the disease course seems to be less favourable. We reviewed the clinical and radiological files of 106 children referred to our institution for the treatment of a symptomatic OPT since 1980. NF1 was present in 51 of them. Progression patterns in children with NF1 differed markedly from those in the other patients. A total of 83 children had tumour extension beyond the chiasm (Dodge type III). Children with NF1 had progressive tumours later during follow-up (47% after the age of 6 years), had more often proptosis and infiltrating tumours but less frequently nystagmus or increased intracranial pressure. 32 children were not treated at diagnosis because they had only mild symptoms related to the OPT. In these patients, progression occurred more often in children without than with NF1 (12/12 versus 12/20 respectively, P = 0.04). A high number of patients needed treatment for progression or severe symptoms after 6 years of age. Of the patients, 33% needed treatment for progression or severe symptoms after 6 years of age.
CONCLUSION: Progression patterns of optic pathway tumours in children with neurofibromatosis type 1 differ markedly from those in other patients. This study emphasises the need for prolonged follow-up of children with optic pathway tumours, especially in neurofibromatosis type 1.

Entities:  

Mesh:

Year:  2000        PMID: 11014471     DOI: 10.1007/s004310000531

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1.

Authors:  D H Gutmann; R Listernick; R E Ferner
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

2.  Suprasellar pilocytic astrocytoma: one national centre's experience.

Authors:  Tafadzwa Mandiwanza; Chandrasekaran Kaliaperumal; Ayman Khalil; Muhammad Sattar; Darach Crimmins; John Caird
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

3.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

Review 4.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

Review 5.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

6.  Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.

Authors:  Anita Villani; David Malkin; Uri Tabori
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 7.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

Review 8.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03

9.  Role of surgery for optic pathway/hypothalamic astrocytomas in children.

Authors:  Yutaka Sawamura; Kyousuke Kamada; Yuuta Kamoshima; Shigeru Yamaguchi; Toshihiro Tajima; Junko Tsubaki; Takamitsu Fujimaki
Journal:  Neuro Oncol       Date:  2008-07-08       Impact factor: 12.300

10.  Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.

Authors:  K Jacob; S Albrecht; C Sollier; D Faury; E Sader; A Montpetit; D Serre; P Hauser; M Garami; L Bognar; Z Hanzely; J L Montes; J Atkinson; J-P Farmer; E Bouffet; C Hawkins; U Tabori; N Jabado
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.